Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso
Clinical trial NCT07624175 · COMPLETED
Trial details
- NCT number
- NCT07624175
- Sponsor
- Kathleen Neuzil
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-17
- Primary completion
- 2024-10-26
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.